Quest Diagnostics Inc (DGX): Operating Cash Flow

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.89B
Year ended 2025-12-31
$1.90B
Trailing 12 months to 2026-06-30
+3.2%
3-year compound annual growth
-1.2%
5-year compound annual growth
$2.23B2007-12-31: $926.92M2008-12-31: $1.06B2009-12-31: $997.42M2010-12-31: $1.12B2011-12-31: $895.00M2012-12-31: $1.19B2013-12-31: $652.00M2014-12-31: $944.00M2015-12-31: $821.00M2016-12-31: $1.12B2017-12-31: $1.18B2018-12-31: $1.20B2019-12-31: $1.24B2020-12-31: $2.00B2021-12-31: $2.23B2022-12-31: $1.72B2023-12-31: $1.27B2024-12-31: $1.33B2025-12-31: $1.89B$1.89B
2007-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$1.89B+41.4%2026-02-26, From 2025-01-01
2024-12-31$1.33B+4.9%2026-02-26, From 2024-01-01
2023-12-31$1.27B-26.0%2026-02-26, From 2023-01-01
2022-12-31$1.72B-23.1%2025-02-20, From 2022-01-01
2021-12-31$2.23B+11.4%2024-02-22, From 2021-01-01
2020-12-31$2.00B+61.3%2023-02-21, From 2020-01-01
2019-12-31$1.24B+3.6%2022-02-28, From 2019-01-01
2018-12-31$1.20B+2.1%2021-02-22, From 2018-01-01
2017-12-31$1.18B+5.3%2020-02-20, From 2017-01-01
2016-12-31$1.12Bn/c2019-02-21, From 2016-01-01
2015-12-31$821.00M-13.0%2018-02-23, From 2015-01-01
2014-12-31$944.00M+44.8%2017-02-22, From 2014-01-01
2013-12-31$652.00M-45.1%2016-02-26, From 2013-01-01
2012-12-31$1.19B+32.6%2015-02-24, From 2012-01-01
2011-12-31$895.00M-19.9%2014-02-18, From 2011-01-01
2010-12-31$1.12B+12.1%2013-02-27, From 2010-01-01
2009-12-31$997.42M-6.2%2012-02-16, From 2009-01-01
2008-12-31$1.06B+14.7%2011-02-16, From 2008-01-01
2007-12-31$926.92Mn/a2010-02-17, From 2007-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Quest Diagnostics Inc (DGX)2025-12-31$1.89B+41.4%
Labcorp Holdings Inc. (LH)2025-12-31$1.64B+3.4%
Fortrea Holdings Inc. (FTRE)2025-12-31$113.50M-56.8%
Natera, Inc. (NTRA)2025-12-31$215.30M+58.7%
RadNet, Inc. (RDNT)2025-12-31$298.82M+28.2%
Guardant Health, Inc. (GH)2025-12-31-$184.76Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$83.16Mn/m
Veracyte, Inc. (VCYT)2025-12-31$136.31M+81.5%
CareDx, Inc. (CDNA)2025-12-31$42.03M+10.5%

Compare DGX, LH, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗